Expert Opinion on Therapeutic Targets
Journal formatting to fit the target journal guidelines
Experts ensure all elements of your paper match journal formatting guidelines to improve publication success rate!
Aims and Scope
Expert Opinion on Therapeutic Targets is a monthly peer-reviewed medical journal publishing review articles and original papers on recently identified novel molecular drug targets across all therapy areas. It was originally established as Emerging Therapeutic Targets in 1997, changing to its current name in 2001. Less
Key Metrics
View Chart Journal Specifications
- PublisherTAYLOR & FRANCIS LTD
- LanguageEnglish
- FrequencyMonthly
- LanguageEnglish
- FrequencyMonthly
- Publication Start Year1997
- Publisher URL
- Website URL
Ready to spotlight your research findings?
Impress peers and journals alike with a concise, visual summary of your work.
Meets Top Publisher Standards: Essential for leading journals like Elsevier.Enhances Engagement: Research papers with graphical abstracts receive 3X more downloads and 8X more shares.Tailored Just for You: We’ll create a custom graphical abstract based on your manuscript—no sketches needed.
3000+ graphical abstracts produced with 4.8/5 customer rating | Months | % Papers published |
|---|---|
| 0-3 | 17% |
| 4-6 | 54% |
| 7-9 | 20% |
| >9 | 10% |
Topics Covered
Year-wise Publication
- 5Y
- 10Y
FAQs
Since when has Expert Opinion on Therapeutic Targets been publishing? 
The Expert Opinion on Therapeutic Targets has been publishing since 1997 till date.
How frequently is the Expert Opinion on Therapeutic Targets published?
Expert Opinion on Therapeutic Targets is published Monthly.
What is the H-index. SNIP score, Citescore and SJR of Expert Opinion on Therapeutic Targets?
Expert Opinion on Therapeutic Targets has a H-index score of 101, Citescore of 9.8, SNIP score of 1.33, & SJR of Q1
Who is the publisher of Expert Opinion on Therapeutic Targets?
The publisher of Expert Opinion on Therapeutic Targets is TAYLOR & FRANCIS LTD.
Where can I find a journal's aims and scope of Expert Opinion on Therapeutic Targets?
For the Expert Opinion on Therapeutic Targets's Aims and Scope, please refer to the section above on the page.
How can I view the journal metrics of Expert Opinion on Therapeutic Targets on editage?
For the Expert Opinion on Therapeutic Targets metrics, please refer to the section above on the page.
What is the eISSN and pISSN number of Expert Opinion on Therapeutic Targets?
The eISSN number is 1744-7631 and pISSN number is 1472-8222 for Expert Opinion on Therapeutic Targets.
What is the focus of this journal?
The journal covers a wide range of topics inlcuding Cancer, Oxidative stress, Sepsis, Lung cancer, Pathophysiology, Tumor microenvironment, Nrf2 pathway, Guanylate cyclase, Glioblastoma, Central nervous system, Alzheimer's disease, Immune checkpoint, Treatment options, Obstructive sleep apnea, Dysbiosis, Pancreatic cancer, Drug discovery, Rheumatoid arthritis, Immunotherapy, Tam receptors.
Why is it important to find the right journal for my research?
Choosing the right journal ensures that your research reaches the most relevant audience, thereby maximizing its scholarly impact and contribution to the field.
Can the choice of journal affect my academic career?
Absolutely. Publishing in reputable journals can enhance your academic profile, making you more competitive for grants, tenure, and other professional opportunities.
Is it advisable to target high-impact journals only?
While high-impact journals offer greater visibility, they are often highly competitive. It's essential to balance the journal's impact factor with the likelihood of your work being accepted.